Shares in Novo Nordisk rose as much as 14% on Thursday after trial data from Eli Lilly's experimental weight-loss pill fell ...

CNBC's Brandon Gomez and Angelica Peebles join 'Power Lunch' to break down the biggest headlines in the pharmaceutical space.

This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members ...

Maziar Mike Doustdar, who was named as Novo Nordisk’s new CEO last week, spoke on a second quarter earnings call of ...

Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...

Second-quarter results mask deeper concerns ​Novo Nordisk's Q2 numbers came in broadly as expected, with headline figures meeting most analyst f ...

Novo Nordisk (NYSE: NVO) is inching down on market open today after President Donald Trump said pharma tariffs could hit 250% ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

Novo Nordisk is a Danish multinational pharmaceutical company that maintains its U.S. headquarters in Plainsboro. - PROVIDED BY NOVO NORDISK Home> Power List 2024> 2024 Power List New Jersey ...

BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported second-quarter profit of $4.03 billion. On a per-share basis, the Bagsvaerd, Denmark-based company said ...

Novo Nordisk and Eli Lilly, the dynamic duo of the weight-loss drug world, still have plenty of upside even after their shares have surged over the past 12 months, analysts say.

Novo Holdings, the Danish drugmaker’s controlling shareholder, said it acquired New Jersey-based Catalent Inc. in a deal that values the contract manufacturer at $16.5 billion. Novo Nordisk, in ...